Document is current
Any future updates will be listed below
-
Authors
Dolkar, Tsering
Gates, Christopher
Hao, Zhonglin
Munker, Reinhold
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05882058 at ClinicalTrials.govnct05652686 at ClinicalTrials.govDocuments that mention this clinical trial
New developments in immunotherapy for SCLC
https://doi.org/10.1136/jitc-2024-009667
nct05680922 at ClinicalTrials.govDocuments that mention this clinical trial
New developments in immunotherapy for SCLC
https://doi.org/10.1136/jitc-2024-009667
nct05680922 at ClinicalTrials.govDocuments that mention this clinical trial
702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer
https://doi.org/10.1136/jitc-2023-sitc2023.0702
New developments in immunotherapy for SCLC
https://doi.org/10.1136/jitc-2024-009667
Documents that mention this clinical trial
702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer
https://doi.org/10.1136/jitc-2023-sitc2023.0702
New developments in immunotherapy for SCLC
https://doi.org/10.1136/jitc-2024-009667
- License Information
